Synthetic biology advances for pharmaceutical production

- Synthetic biology is quickly moving from proof of concept to industrial application.
- Pharmaceuticals are a promising target for advanced genetic engineering.
- Genome sequence data indicate vast underexploited biosynthetic capacity.
- Synthetic biology can create libraries of novel chemicals enriched for bioactivity.
- Synthetic biology expands the range of available chassis organisms for industry.